{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:13:33Z","timestamp":1767964413890,"version":"3.49.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"S7","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1186\/s12859-017-1637-5","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T09:22:29Z","timestamp":1496222549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Drug repositioning for enzyme modulator based on human metabolite-likeness"],"prefix":"10.1186","volume":"18","author":[{"given":"Yoon Hyeok","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hojae","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seongyong","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwan-Su","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,31]]},"reference":[{"issue":"11","key":"1637_CR1","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","volume":"4","author":"AL Hopkins","year":"2008","unstructured":"Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008;4(11):682\u201390.","journal-title":"Nat Chem Biol"},{"issue":"5","key":"1637_CR2","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.drudis.2013.11.005","volume":"19","author":"G Jin","year":"2014","unstructured":"Jin G, Wong ST. Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines. Drug Discov Today. 2014;19(5):637\u201344.","journal-title":"Drug Discov Today"},{"issue":"1","key":"1637_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.bjp.0707305","volume":"152","author":"S Ekins","year":"2007","unstructured":"Ekins S, Mestres J, Testa B. In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling. Br J Pharmacol. 2007;152(1):9\u201320.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"1637_CR4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.copbio.2009.08.003","volume":"20","author":"P Kolb","year":"2009","unstructured":"Kolb P, Ferreira RS, Irwin JJ, Shoichet BK. Docking and chemoinformatic screens for new ligands and targets. Curr Opin Biotechnol. 2009;20(4):429\u201336.","journal-title":"Curr Opin Biotechnol"},{"issue":"4","key":"1637_CR5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/bib\/bbr028","volume":"12","author":"SJ Swamidass","year":"2011","unstructured":"Swamidass SJ. Mining small-molecule screens to repurpose drugs. Brief Bioinform. 2011;12(4):327\u201335.","journal-title":"Brief Bioinform"},{"issue":"16","key":"1637_CR6","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1093\/bioinformatics\/btt307","volume":"29","author":"S Alaimo","year":"2013","unstructured":"Alaimo S, Pulvirenti A, Giugno R, Ferro A. Drug\u2013target interaction prediction through domain-tuned network-based inference. Bioinformatics. 2013;29(16):2004\u20138.","journal-title":"Bioinformatics"},{"issue":"12","key":"1637_CR7","doi-asserted-by":"crossref","first-page":"e28025","DOI":"10.1371\/journal.pone.0028025","volume":"6","author":"L Yang","year":"2011","unstructured":"Yang L, Agarwal P. Systematic drug repositioning based on clinical side-effects. PLoS One. 2011;6(12):e28025.","journal-title":"PLoS One"},{"issue":"15","key":"1637_CR8","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1186\/1471-2105-13-S15-S6","volume":"13","author":"H Bisgin","year":"2012","unstructured":"Bisgin H, Liu Z, Kelly R, Fang H, Xu X, Tong W. Investigating drug repositioning opportunities in FDA drug labels through topic modeling. BMC Bioinf. 2012;13(15):S6.","journal-title":"BMC Bioinf."},{"issue":"4","key":"1637_CR9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nbt.2151","volume":"30","author":"P Sanseau","year":"2012","unstructured":"Sanseau P, Agarwal P, Barnes MR, Pastinen T, Richards JB, Cardon LR, Mooser V. Use of genome-wide association studies for drug repositioning. Nat Biotechnol. 2012;30(4):317\u201320.","journal-title":"Nat Biotechnol"},{"issue":"23","key":"1637_CR10","first-page":"1289","volume":"17","author":"XA Qu","year":"2012","unstructured":"Qu XA, Rajpal DK. Applications of Connectivity Map in drug discovery and development. Drug Discov Today. 2012;17(23):1289\u201398.","journal-title":"Drug Discov Today"},{"issue":"96","key":"1637_CR11","doi-asserted-by":"crossref","first-page":"96ps35","DOI":"10.1126\/scitranslmed.3001512","volume":"3","author":"YA Lussier","year":"2011","unstructured":"Lussier YA, Chen JL. The emergence of genome-based drug repositioning. Sci Transl Med. 2011;3(96):96ps35.","journal-title":"Sci Transl Med"},{"issue":"20","key":"1637_CR12","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1158\/0008-5472.CAN-12-4617","volume":"73","author":"H Zhao","year":"2013","unstructured":"Zhao H, Jin G, Cui K, Ren D, Liu T, Chen P, Wong S, Li F, Fan Y, Rodriguez A. Novel modeling of cancer cell signaling pathways enables systematic drug repositioning for distinct breast cancer metastases. Cancer Res. 2013;73(20):6149\u201363.","journal-title":"Cancer Res"},{"issue":"33","key":"1637_CR13","doi-asserted-by":"crossref","first-page":"14621","DOI":"10.1073\/pnas.1000138107","volume":"107","author":"F Iorio","year":"2010","unstructured":"Iorio F, Bosotti R, Scacheri E, Belcastro V, Mithbaokar P, Ferriero R, Murino L, Tagliaferri R, Brunetti-Pierri N, Isacchi A. Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc Natl Acad Sci. 2010;107(33):14621\u20136.","journal-title":"Proc Natl Acad Sci"},{"key":"1637_CR14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.ne.07.030184.001521","volume":"7","author":"AI Basbaum","year":"1984","unstructured":"Basbaum AI, Fields HL. Endogenous Pain Control-Systems - Brain-Stem Spinal Pathways and Endorphin Circuitry. Annu Rev Neurosci. 1984;7:309\u201338.","journal-title":"Annu Rev Neurosci"},{"issue":"5\u20136","key":"1637_CR15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","volume":"110","author":"JR Vane","year":"2003","unstructured":"Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res. 2003;110(5\u20136):255\u20138.","journal-title":"Thromb Res"},{"issue":"24","key":"1637_CR16","doi-asserted-by":"crossref","first-page":"11648","DOI":"10.1021\/jf800974z","volume":"56","author":"JR Paterson","year":"2008","unstructured":"Paterson JR, Baxter G, Dreyer JS, Halket JM, Flynn R, Lawrence JR. Salicylic Acid sans Aspirin in Animals and Man: Persistence in Fasting and Biosynthesis from Benzoic Acid. J Agric Food Chem. 2008;56(24):11648\u201352.","journal-title":"J. Agric. Food Chem."},{"issue":"1\u20132","key":"1637_CR17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.drudis.2008.10.011","volume":"14","author":"PD Dobson","year":"2009","unstructured":"Dobson PD, Patel Y, Kell DB. Metabolite-likeness\u2019 as a criterion in the design and selection of pharmaceutical drug libraries. Drug Discov Today. 2009;14(1\u20132):31\u201340.","journal-title":"Drug Discov Today"},{"issue":"2","key":"1637_CR18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrd.2015.44","volume":"15","author":"DB Kell","year":"2016","unstructured":"Kell DB. Implications of endogenous roles of transporters for drug discovery: hitchhiking and metabolite-likeness. Nat Rev Drug Discov. 2016;15(2):143.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"1637_CR19","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11306-014-0745-8","volume":"11","author":"S O\u2019Hagan","year":"2015","unstructured":"O\u2019Hagan S, Swainston N, Handl J, Kell DB. A \u2018rule of 0.5\u2032 for the metabolite-likeness of approved pharmaceutical drugs. Metabolomics. 2015;11(2):340.","journal-title":"Metabolomics"},{"issue":"W1","key":"1637_CR20","doi-asserted-by":"crossref","first-page":"W32","DOI":"10.1093\/nar\/gku293","volume":"42","author":"D Gfeller","year":"2014","unstructured":"Gfeller D, Grosdidier A, Wirth M, Daina A, Michielin O, Zoete V. SwissTargetPrediction: a web server for target prediction of bioactive small molecules. Nucleic Acids Res. 2014;42(W1):W32\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1637_CR21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10822-016-9915-2","volume":"30","author":"Z-J Yao","year":"2016","unstructured":"Yao Z-J, Dong J, Che Y-J, Zhu M-F, Wen M, Wang N-N, Wang S, Lu A-P, Cao D-S. TargetNet: a web service for predicting potential drug\u2013target interaction profiling via multi-target SAR models. J Comput Aided Mol Des. 2016;30(5):413\u201324.","journal-title":"J Comput Aided Mol Des"},{"issue":"6","key":"1637_CR22","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1021\/ci6004299","volume":"47","author":"SN Rao","year":"2007","unstructured":"Rao SN, Head MS, Kulkarni A, LaLonde JM. Validation studies of the site-directed docking program LibDock. J Chem Inf Model. 2007;47(6):2159\u201371.","journal-title":"J Chem Inf Model"},{"issue":"14","key":"1637_CR23","doi-asserted-by":"crossref","first-page":"7704","DOI":"10.1073\/pnas.110153997","volume":"97","author":"HJ Morowitz","year":"2000","unstructured":"Morowitz HJ, Kostelnik JD, Yang J, Cody GD. The origin of intermediary metabolism. P Natl Acad Sci USA. 2000;97(14):7704\u20138.","journal-title":"P Natl Acad Sci USA"},{"issue":"D1","key":"1637_CR24","doi-asserted-by":"crossref","first-page":"D801","DOI":"10.1093\/nar\/gks1065","volume":"41","author":"DS Wishart","year":"2013","unstructured":"Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, Liu YF, Djoumbou Y, Mandal R, Aziat F, Dong E, et al. HMDB 3.0-The Human Metabolome Database in. Nucleic Acids Res 2013. 2013;41(D1):D801\u20137.","journal-title":"Nucleic Acids Res 2013"},{"issue":"D1","key":"1637_CR25","doi-asserted-by":"crossref","first-page":"D456","DOI":"10.1093\/nar\/gks1146","volume":"41","author":"J Hastings","year":"2013","unstructured":"Hastings J, de Matos P, Dekker A, Ennis M, Harsha B, Kale N, Muthukrishnan V, Owen G, Turner S, Williams M, et al. The ChEBI reference database and ontology for biologically relevant chemistry: enhancements for 2013. Nucleic Acids Res. 2013;41(D1):D456\u201363.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"1637_CR26","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","volume":"44","author":"S Kim","year":"2016","unstructured":"Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, Han LY, He JE, He SQ, Shoemaker BA, et al. PubChem Substance and Compound databases. Nucleic Acids Res. 2016;44(D1):D1202\u201313.","journal-title":"Nucleic Acids Res"},{"key":"1637_CR27","doi-asserted-by":"crossref","first-page":"D668","DOI":"10.1093\/nar\/gkj067","volume":"34","author":"DS Wishart","year":"2006","unstructured":"Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, Chang Z, Woolsey J. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006;34:D668\u201372.","journal-title":"Nucleic Acids Res"},{"key":"1637_CR28","doi-asserted-by":"crossref","unstructured":"Riniker S, Landrum GA. Open-source platform to benchmark fingerprints for ligand-based virtual screening. J Cheminformatics. 2013;5(1):26.","DOI":"10.1186\/1758-2946-5-26"},{"issue":"6","key":"1637_CR29","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1021\/ci010132r","volume":"42","author":"JL Durant","year":"2002","unstructured":"Durant JL, Leland BA, Henry DR, Nourse JG. Reoptimization of MDL keys for use in drug discovery. J Chem Inf Comp Sci. 2002;42(6):1273\u201380.","journal-title":"J Chem Inf Comp Sci"},{"issue":"23\u201324","key":"1637_CR30","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.drudis.2006.10.005","volume":"11","author":"P Willett","year":"2006","unstructured":"Willett P. Similarity-based virtual screening using 2D fingerprints. Drug Discov Today. 2006;11(23\u201324):1046\u201353.","journal-title":"Drug Discov Today"},{"issue":"8","key":"1637_CR31","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1021\/jm401411z","volume":"57","author":"G Maggiora","year":"2013","unstructured":"Maggiora G, Vogt M, Stumpfe D, Bajorath J. Molecular Similarity in Medicinal Chemistry: Miniperspective. J Med Chem. 2013;57(8):3186\u2013204.","journal-title":"J Med Chem"},{"key":"1637_CR32","unstructured":"Warnes MGR, Bolker B, Bonebakker L: Package \u2018gplots\u2019. Various R Programming Tools for Plotting Data 2016"},{"key":"1637_CR33","volume-title":"R: A language and environment for statistical computing","author":"RC Team","year":"2016","unstructured":"Team RC. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2016. URL https:\/\/www.R-project.org\/."},{"issue":"3","key":"1637_CR34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/1467-8306.00061","volume":"87","author":"CA Brewer","year":"1997","unstructured":"Brewer CA, MacEachren AM, Pickle LW, Herrmann D. Mapping mortality: Evaluating color schemes for choropleth maps. Ann Assoc Am Geogr. 1997;87(3):411\u201338.","journal-title":"Ann Assoc Am Geogr"},{"issue":"D1","key":"1637_CR35","doi-asserted-by":"crossref","first-page":"D204","DOI":"10.1093\/nar\/gku989","volume":"43","author":"U Consortium","year":"2015","unstructured":"Consortium U. UniProt: a hub for protein information. Nucleic Acids Res. 2015;43(D1):D204\u201312.","journal-title":"Nucleic Acids Res"},{"key":"1637_CR36","doi-asserted-by":"crossref","first-page":"D431","DOI":"10.1093\/nar\/gkh081","volume":"32","author":"I Schomburg","year":"2004","unstructured":"Schomburg I, Chang A, Ebeling C, Gremse M, Heldt C, Huhn G, Schomburg D. BRENDA, the enzyme database: updates and major new developments. Nucleic Acids Res. 2004;32:D431\u20133.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1637_CR37","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nbt.2488","volume":"31","author":"I Thiele","year":"2013","unstructured":"Thiele I, Swainston N, Fleming RMT, Hoppe A, Sahoo S, Aurich MK, Haraldsdottir H, Mo ML, Rolfsson O, Stobbe MD, et al. A community-driven global reconstruction of human metabolism. Nat Biotechnol. 2013;31(5):419.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"1637_CR38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"40","key":"1637_CR39","doi-asserted-by":"crossref","first-page":"9467","DOI":"10.1021\/bi00492a021","volume":"29","author":"JF Davies","year":"1990","unstructured":"Davies JF, Delcamp TJ, Prendergast NJ, Ashford VA, Freisheim JH, Kraut J. Crystal-Structures of Recombinant Human Dihydrofolate-Reductase Complexed with Folate and 5-Deazafolate. Biochemistry-Us. 1990;29(40):9467\u201379.","journal-title":"Biochemistry-Us"},{"issue":"7","key":"1637_CR40","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1021\/bi002413i","volume":"40","author":"J Phan","year":"2001","unstructured":"Phan J, Koli S, Minor W, Dunlap RB, Berger SH, Lebioda L. Human thymidylate synthase is in the closed conformation when complexed with dUMP and raltitrexed, an antifolate drug. Biochemistry-Us. 2001;40(7):1897\u2013902.","journal-title":"Biochemistry-Us"},{"issue":"20","key":"1637_CR41","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1093\/bioinformatics\/bti623","volume":"21","author":"T Sing","year":"2005","unstructured":"Sing T, Sander O, Beerenwinkel N, Lengauer T. ROCR: visualizing classifier performance in R. Bioinformatics. 2005;21(20):3940\u20131.","journal-title":"Bioinformatics"},{"issue":"4","key":"1637_CR42","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/bimj.200410135","volume":"47","author":"R Fluss","year":"2005","unstructured":"Fluss R, Faraggi D, Reiser B. Estimation of the Youden index and its associated cutoff point. Biometrical J. 2005;47(4):458\u201372.","journal-title":"Biometrical J"},{"issue":"4","key":"1637_CR43","first-page":"337","volume":"2","author":"PD Cole","year":"2006","unstructured":"Cole PD, Zebala JA, Kamen BA. Antimetabolites: A new perspective. Drug Discovery Today: Therapeutic Strategies. 2006;2(4):337\u201342.","journal-title":"Drug Discovery Today: Therapeutic Strategies"},{"issue":"9","key":"1637_CR44","doi-asserted-by":"crossref","first-page":"e0163961","DOI":"10.1371\/journal.pone.0163961","volume":"11","author":"H Tsukihara","year":"2016","unstructured":"Tsukihara H, Tsunekuni K, Takechi T. Folic Acid- Metabolizing Enzymes Regulate the Antitumor Effect of 5-Fluoro-2\u2032- Deoxyuridine in Colorectal Cancer Cell Lines. PLoS One. 2016;11(9):e0163961.","journal-title":"PLoS One"},{"issue":"1","key":"1637_CR45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0026-895X(25)14371-X","volume":"24","author":"J Bouchard","year":"1983","unstructured":"Bouchard J, Momparler R. Incorporation of 5- Aza-2\u2032-deoxycytidine-5\u2032-triphosphate into DNA. Interactions with mammalian DNA polymerase alpha and DNA methylase. Mol Pharmacol. 1983;24(1):109\u201314.","journal-title":"Mol Pharmacol"},{"key":"1637_CR46","doi-asserted-by":"crossref","unstructured":"Hollenbach PW, Nguyen AN, Brady H, Williams M, Ning Y, Richard N, Krushel L, Aukerman SL, Heise C, MacBeth KJ. A comparison of azacitidine and decitabine activities in acute myeloid leukemia cell lines. e9001. 2010;5(2).","DOI":"10.1371\/journal.pone.0009001"},{"issue":"5","key":"1637_CR47","first-page":"2320","volume":"61","author":"MT Hartsough","year":"2001","unstructured":"Hartsough MT, Clare SE, Mair M, Elkahloun AG, Sgroi D, Osborne CK, Clark G, Steeg PS. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition. Cancer Res. 2001;61(5):2320\u20137.","journal-title":"Cancer Res"},{"issue":"11","key":"1637_CR48","doi-asserted-by":"crossref","first-page":"e112619","DOI":"10.1371\/journal.pone.0112619","volume":"9","author":"GJ Cook","year":"2014","unstructured":"Cook GJ, Caudell DL, Elford HL, Pardee TS. The efficacy of the ribonucleotide reductase inhibitor didox in preclinical models of AML. PLoS One. 2014;9(11):e112619.","journal-title":"PLoS One"},{"issue":"11","key":"1637_CR49","doi-asserted-by":"crossref","first-page":"e14060","DOI":"10.1371\/journal.pone.0014060","volume":"5","author":"A Sch\u00e4fer","year":"2010","unstructured":"Sch\u00e4fer A, Schomacher L, Barreto G, D\u00f6derlein G, Niehrs C. Gemcitabine functions epigenetically by inhibiting repair mediated DNA demethylation. PLoS One. 2010;5(11):e14060.","journal-title":"PLoS One"},{"key":"1637_CR50","doi-asserted-by":"crossref","unstructured":"Cuny GD, Suebsuwong C, Ray SS: Inosine-5\u2032-monophosphate dehydrogenase (IMPDH) inhibitors: a patent and scientific literature review (2002\u20132016). Expert Opinion on Therapeutic Patents 2017(just-accepted).","DOI":"10.1080\/13543776.2017.1280463"},{"issue":"14","key":"1637_CR51","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1016\/j.bmc.2016.05.046","volume":"24","author":"S-Y Lee","year":"2016","unstructured":"Lee S-Y, Perotti A, De Jonghe S, Herdewijn P, Hanck T, M\u00fcller CE. Thiazolo [3, 2-a] benzimidazol-3 (2H)-one derivatives: Structure\u2013activity relationships of selective nucleotide pyrophosphatase\/phosphodiesterase1 (NPP1) inhibitors. Bioorg Med Chem. 2016;24(14):3157\u201365.","journal-title":"Bioorg Med Chem"},{"key":"1637_CR52","doi-asserted-by":"crossref","unstructured":"Shemesh E, Deroma L, Bembi B, Deegan P, Hollak C, Weinreb NJ, Cox TM. Enzyme replacement and substrate reduction therapy for Gaucher disease. Cochrane Db Syst Rev. 2015;(3):CD010324.","DOI":"10.1002\/14651858.CD010324.pub2"},{"issue":"6","key":"1637_CR53","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1023\/A:1025902113005","volume":"26","author":"TM Cox","year":"2003","unstructured":"Cox TM, Aerts JMFG, Andria G, Beck M, Belmatoug N, Bembi B, Chertkoff R, Vom Dahl S, Elstein D, Erikson A, et al. The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: A position statement. J Inherit Metab Dis. 2003;26(6):513\u201326.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"1637_CR54","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bcmd.2008.11.002","volume":"42","author":"G Sanchez-Olle","year":"2009","unstructured":"Sanchez-Olle G, Duque J, Egido-Gabas M, Casas J, Lluch M, Chabas A, Grinberg D, Vilageliu L. Promising results of the chaperone effect caused by iminosugars and aminocyclitol derivatives on mutant glucocerebrosidases causing Gaucher disease. Blood Cell Mol Dis. 2009;42(2):159\u201366.","journal-title":"Blood Cell Mol Dis"},{"issue":"6","key":"1637_CR55","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1023\/A:1025902113005","volume":"26","author":"T Cox","year":"2003","unstructured":"Cox T, Aerts JM, Andria G, Beck M, Belmatoug N, Bembi B, Chertkoff R, Vom Dahl S, Elstein D, Erikson A. The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement. J Inherit Metab Dis. 2003;26(6):513\u201326.","journal-title":"J Inherit Metab Dis"},{"issue":"11","key":"1637_CR56","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1038\/mt.2014.138","volume":"22","author":"G Parenti","year":"2014","unstructured":"Parenti G, Fecarotta S, la Marce G, Rossi B, Ascione S, Donati MA, Morandis LO, Ravaglia S, Pichiecchio A, Ombrone D, et al. A Chaperone Enhances Blood alpha-Glucosidase Activity in Pompe Disease Patients Treated With Enzyme Replacement Therapy. Mol Ther. 2014;22(11):2004\u201312.","journal-title":"Mol Ther"},{"issue":"4","key":"1637_CR57","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ymgme.2008.12.008","volume":"96","author":"B Rigat","year":"2009","unstructured":"Rigat B, Mahuran D. Diltiazem, a L-type Ca2+ channel blocker, also acts as a pharmacological chaperone in Gaucher patient cells. Mol Genet Metab. 2009;96(4):225\u201332.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"1637_CR58","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bcmd.2012.10.007","volume":"50","author":"I Bendikov-Bar","year":"2013","unstructured":"Bendikov-Bar I, Maor G, Filocamo M, Horowitz M. Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase. Blood Cell Mol Dis. 2013;50(2):141\u20135.","journal-title":"Blood Cell Mol Dis"},{"key":"1637_CR59","doi-asserted-by":"crossref","unstructured":"Mele BH, Citro V, Andreotti G, Cubellis MV. Drug repositioning can accelerate discovery of pharmacological chaperones. Orphanet J Rare Dis. 2015;10:55.","DOI":"10.1186\/s13023-015-0273-2"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-017-1637-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T21:40:25Z","timestamp":1750282825000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-017-1637-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":59,"journal-issue":{"issue":"S7","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["1637"],"URL":"https:\/\/doi.org\/10.1186\/s12859-017-1637-5","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5]]},"article-number":"226"}}